Thyronorm 5 mg/ml Oral Solution for Cats
Thyronorm 5 mg/ml Oral Solution for Cats
Authorised
- Thiamazole
Product identification
Medicine name:
Thyronorm 5 mg/ml Oral Solution for Cats
Apelka, 5mg/ml, Perorální roztok
Active substance:
- Thiamazole
Target species:
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Thiamazole5.00milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Oral solution
Withdrawal period by route of administration:
-
Oral use
- Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QH03BB02
Legal status of supply:
This information is not available for this product.
Authorisation status:
-
Valid
Authorised in:
-
Czechia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Norbrook Laboratories (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Norbrook Laboratories Limited
- Norbrook Manufacturing Limited
Responsible authority:
- Institute For State Control Of Veterinary Biologicals And Medicines
Authorisation number:
- 96/062/16-C
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0548/001
Concerned member states:
-
Austria
-
Belgium
-
Czechia
-
Denmark
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Italy
-
Luxembourg
-
Norway
-
Portugal
-
Slovakia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 28/01/2022
Czech (PDF)
Published on: 2/02/2024
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 2/02/2024
Labelling
This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 25/10/2022
How useful was this page?: